Finasteride in the treatment of Japanese men with male pattern hair loss.
Finasteride is a type 2 5 alpha-reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone, a key mediator of male pattern hair loss (androgenetic alopecia). The objective of this study was to identify the optimal dosage of finasteride and to evaluate its efficacy and safety in the treatment of Japanese men with male pattern hair loss. In this double- blind randomized study, 414 Japanese men with male pattern hair loss received finasteride 1 mg (n = 139), finasteride 0.2 mg (n = 137), or placebo (n = 38) once daily for 48 weeks. Efficacy was evaluated by global photographic assessment, patient self-assessment, and investigator assessment. All efficacy endpoints showed significant improvement with finasteride therapy by 12 weeks (p < 0.05 versus placebo). At 48 weeks, 58%, 54%, and 6% of men in the finasteride 1 mg, finasteride 0.2 mg, and placebo groups, respectively, had improved based on assessments of global photographs. All efficacy endpoints were numerically superior for the 1 mg dose over the 0.2 mg dose at 48 weeks. Finasteride treatment was generally well tolerated. Finasteride 1 mg\day slows hair loss and improves hair growth in Japanese men with male pattern hair loss.
Kawashima
Makoto
M
Tokyo Women's Medical University, School of Medicine, Department of Dermatology 8-1, Kawada-cho, Shinjuku Tokyo, 162-8666 Japan. m-kawash@derm.twmu.ac.jp
Hayashi
Nobukazu
N
Igarashi
Atsuyuki
A
Kitahara
Hirohito
H
Maeguchi
Mizue
M
Mizuno
Atsuko
A
Murata
Yasuko
Y
Nogita
Toshitatsu
T
Toda
Kiyoshi
K
Tsuboi
Ryoji
R
Ueki
Rie
R
Yamada
Mina
M
Yamazaki
Masashi
M
Matsuda
Takuma
T
Natsumeda
Yutaka
Y
Takahashi
Kihito
K
Harada
Shotaro
S
D058891:5-alpha Reductase Inhibitors; D000328:Adult; D000505:Alopecia / Q000188:drug therapy* / Q000473:pathology; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D018120:Finasteride / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D058891:5-alpha Reductase Inhibitors; D004791:Enzyme Inhibitors; D018120:Finasteride